Oncolytics Biotech Inc.

NASDAQ: ONCY · Healthcare · Biotechnology

Canadian filerHQ Calgary, ABCIK 0001129928Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 13DQ —GM —SS 63

v0.1 · 35/100 weight · pillars only

↑ listing tenure, market scale · ↓ Piotroski F, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$28.8M

Employees

Market cap

$90.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$28.8M-$28.8M2025

Operating income-$28.7M-$28.7M2025

Total assets$7.6M$7.6M2025

Liabilities$11.4M$11.4M2025

Equity-$3.8M-$3.8M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Oncolytics Biotech Inc. earned -$28.8M in FY2025 net income.

Peers · Healthcare

enGene Holdings Inc.——Lixte Biotechnology Holdings, Inc.41D Seer, Inc.49D SANUWAVE Health Inc.74B

Key facts

CEOJared Kelly

SectorHealthcare

IndustryBiotechnology

HeadquartersCalgary, AB

ExchangeNASDAQ: ONCY

Employees29

IPO date2001-10-05

Latest filings

8-K2026-07-08 8-K2026-06-16 8-K2026-06-02 8-K2026-06-01 8-K2026-05-22 10-Q2026-05-14 8-K2026-05-04 8-K2026-04-27

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.